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Abstract
Background: The role of IL-17 producing cells in tumors is controversial. In the present study, we investigated the
prognostic value of measuring tumor-infiltrating IL-17 producing cell levels in human esophageal squamous cell carcinoma
(ESCC).
Methodology/Principal Findings: Immunohistochemical staining was performed to investigate the levels of IL-17+ tumor
infiltrating lymphocytes (TILs), as well as CD8+ cytotoxic T lymphocytes (CTLs) and CD57+ natural killer (NK) cells from 181
ESCC patients. The prognostic value of measuring the densities of IL-17+TILs and the correlation with CTLs and NK was
evaluated. IL-17 producing cells were detected in esophageal squamous cell carcinoma tissues. The IL-17 producing cells
were major CD4 positive, but Foxp3 negative. The median level of IL-17+TILs was 3.90 cells/high power microscopic field
(HPF). The density of IL-17 producing cells correlated negatively with T stage (P=0.042). The higher densities of tumor
infiltrating IL-17+ lymphocytes were associated with better overall survival (P=0.031). Furthermore, we found that there
were positive correlations between levels of IL-17 producing cells and the densities of CD8+cells, as well as CD57+cells
(r=0.198, P=0.008 for CD8+ cells and r=0.261, P,0.001 for CD57+ cells, respectively). The prognosis analysis also showed
that the higher levels of CD8+ CTLs and CD57+ NK cells correlated with better overall survival of ESCC patients.
Conclusions: Our study suggests that tumor infiltrating IL-17 producing cells in ESCC patients may have protective roles in
the tumor microenvironment and may be treated as a prognostic marker for ESCC patients.
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Introduction
Substantial evidence indicates that the abundance of tumor-
infiltrating lymphocytes in the microenvironment of certain tumor
types is associated with the prognosis of cancer patients. Moreover,
each subset of tumor-infiltrating lymphocytes has a unique role in
the antitumor response [1–4]. The presence of tumor-infiltrating
cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells
correlates with improved survival and confers antitumor activity
[5]. However, other tumor-infiltrating lymphocyte subsets exhibit
bipolar roles: promoting tumor growth or inhibiting tumor
progression [6]. These subsets include the newly identified
tumor-infiltrating IL-17 producing cells. Interleukin-17 (IL-17),
originally termed CTLA-8, plays an important role in inflamma-
tion and autoimmune diseases in both mice and humans [7–13].
Early research focused on the roles and mechanisms of IL-17
producing cells in inflammation and autoimmune diseases.
Because chronic inflammation were correlated significantly to
tumor invasion, migration and metastasis [14,15], scientists have
begun to pay more attention to the significance of IL-17 in tumor
models. There is accumulating evidence that IL-17 producing cells
are present in various cancers, including ovarian cancer, breast
cancer, non-small cell lung cancer, hepatocellular carcinoma and
gastric cancer [16–19]. Substantial evidence indicated that IL-17
was produced mainly by CD4+ T lymphocytes, and these cells
were defined as T helper 17 (Th 17) cells [14,15,20]. However, in
recent studies, it was found that other T cell subsets can also
produce IL-17, such as NKT, gamma-delta T cells and Tregs,
including mouse models and human beings [14,20–26]. Although
IL-17 producing cells have been detected in various tumors, their
effect on tumor cell survival and exact physiological role in tumor
immunity remain controversial. IL-17 producing cells could
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Conversely, IL-17 producing cells might promote tumor regres-
sion by enhancing antitumor immunity [15,27–30].
Esophageal squamous cell carcinoma (ESCC) is the major
histological type of esophageal cancer in the "Esophageal Cancer
Belt," which stretches westward from China through central Asia
to northern Iran [31,32]. ESCC is the eighth most common
cancer worldwide [33], and ranks the sixth cancer mortality
worldwide [34]. It was reported that the host immune response
prompted by ESCC may influence patient prognosis; both
adaptive and innate immunity play important roles in ESCC
progression and regression [35–38]. Yasushi et al showed that the
number of CD8+ T cells correlated with favorable outcomes in
ESCC patients [39]. Hsia et al found that ESCC patient prognosis
correlated positively with intratumoral NK cell infiltration [36].
Xue et al found that FOXP3 expression was associated with lymph
node metastasis and pathological TNM staging, suggesting that
regulatory T cells (Tregs) might promote tumor progression [38].
However, up until now, the presence and clinical significance of
IL-17 producing cells have not been previously studied in ESCC.
Thus, in this study, we evaluated the accumulation and
clinicopathological significance of tumor-infiltrating IL-17 pro-
ducing cells in tumor tissues from ESCC patients. The prognosis
value of IL-17 producing cells was also evaluated. Furthermore,
we detected CD8+ CTLs and CD57+ NK cells in the same tumor
tissues and relationships between the number of IL-17 producing
cells and the density of CD8+ CTLs or CD57+ NK cells were
further evaluated.
Results
Immunohistochemical staining of IL-17 producing cells
and their associations with clinicopathological
characteristics
The representative photomicrographs of tissue sections immu-
nostained for IL-17 are shown in Figure 1. IL-17 producing cells
were detected in esophageal squamous cell carcinoma tissue. In
order to clarify which set of T cells could produce IL-17, double
immunohistochemical staining was performed in the same tissue
section. Immunofiuorescence results showed that IL-17 producing
cells were major CD4 positive, but FOXP3 negative in ESCC
tissues (Figure 1). The median value of IL-17 producing cells was
3.90 cells/HPF (range: 0.00–21.40 cells/HPF).
The associations between the levels of IL-17 producing cells
and clinicopathological factors of the ESCC patients are
summarized in Table 1. According to previous studies, patients
were divided into two groups based on the median of IL-17
producing cells (high level group vs. low level group) [4,18].
There was a significant inverse correlation between the densities
Figure 1. Representative immunohistochemical staining photomicrographs of IL-17 producing cells in tumor tissues of ESCC.
Positive staining of IL-17 was detected in cellular cytoplasm of tumor tissues. (A), (B), (E) and (F): Low density of IL-17+ TILs. (C), (D), (G) and (H): High
density of IL-17+ TILs. (J) and (K): Double stainings of CD4 (green, on the menbrane) and IL-17 (red, in the cytoplasm), IL-17 (green, in the cytoplasm)
and FOXP3 (red, nuclei) in paraffin-embedded specimens were analyzed by immunofiuorescence. Original magnification: A–D6200; E–K6400.
doi:10.1371/journal.pone.0018219.g001
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P=0.042).
Correlation between the densities of IL-17 producing
cells and patients’ survival
The median survival time of the 181 ESCC patients was 44
months (range 1–87 months). The five-year survival rate was
49.9%. The overall survival curves of the patients in this study are
depicted in Figure 2. The statistical analysis demonstrated a
positive correlation between overall survival and the density of IL-
17+ TILs (Figure 2, long-rank test: P=0.031).
The univariate analysis demonstrated that IL-17 producing cell
density (P=0.006), differentiation (P=0.006), T (depth of tumor
invasion, P=0.002), N (lymph node metastases, P,0.001) and
TNM staging (P,0.001) were significantly associated with overall
survival (Table 2). The subsequent multivariate analysis, however,
indicated that only differentiation was an independent predictor
for overall survival in ESCC (P=0.030, Table 2).
Relationship between the levels of IL-17+ TILs and CD8+
CTLs cells as well as CD57+ NK cells in tumor
microenvironment
ThelevelsofCD8+ CTLs and CD57+ NKcellsintumortissuein
ESCC patients were evaluated. In addition, the Pearson correlation
coefficient was calculated, and linear regression analysis was applied
to assess the relationships between the IL-17 producing cells and
CD8+ CTLs or CD57+ NK cells in the tumor microenvironment.
Infiltrating CD8+ CTLs and CD57+ NK cells were detected in
tumor tissues by immunohistochemical staining (Figure 3), and
statistical analysis showed that the levels of IL-17 producing cells
positively correlated with levels of CD8+ CTLs in tumor tissues
(r=0.198, P=0.008, Figure 4A). A significant association was also
identifiedbetweenthedensitiesofIL-17+TILsandCD57+NKcells
(r=0.261, P,0.001, Figure 4B). From prognosis analysis, we found
that higher levels of infiltrating CD8+ CTLs or CD57+NK cells
correlated with a better overall survival of ESCC patients (P,0.001
and P=0.002, respectively, determined by long-rank test, Figure 5).
Table 1. Relationship between IL-17 producing cell density and clinical-pathologic factors.
Variables Number of Patients IL-17 producing cell density P value
Low level group, n=90 High level group, n=91
Age(years) 0.506
,60 105 50 55
$60 76 40 36
Gender 0.080
Male 141 75 66
Female 40 15 25
Tumor length (cm) 0.110
,57 5 3 2 4 3
$5 106 58 48
Differentiation 0.199
G1 45 26 19
G2 85 39 46
G3 51 25 26
Location 0.952
Upper third 13 6 7
Middle third 113 56 57
Lower third 55 28 27
T 0.042
*
T1+T2 57 22 35
T3+T4 124 68 56
N 0.335
No 101 47 54
Yes 80 43 37
M 0.444
M0 175 86 89
M1 6 4 2
TNM staging 0.177
Stage I-II 117 53 64
Stage III-IV 64 37 27
G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated; T, depth of primary tumor invasion; N, regional lymph nodes; M, distant metastasis; TNM,
tumor-lymph node-metastasis classification.
* Statistically significant (P,0.05).
doi:10.1371/journal.pone.0018219.t001
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Accumulating evidence suggests that IL-17 producing cells play a
significant role in tumor immunity. However, IL-17 may play
pro-tumor or anti-tumor effects in different tumor contexts
[14,18,27,28,40]. Zhang et al found that IL-17 producing cells
could promote tumor growth by stimulating angiogenesis in
hepatocellular carcinoma patients [18]. Conversely, Kryczek et al
demonstrated that IL-17 promoted antitumor activity in ovarian
cancer patients [28]. The explanation for this discrepancy remains
unknown.
We first detected tumor-infiltrating-IL-17 producing cells in
human esophageal squamous cell carcinoma (ESCC) and observed
that the levels of IL-17 producing cells correlated inversely with T
Figure 2. Kaplan–Meier survival curves of ESCC patients (n=181) after surgical resection. Increased IL-17-producing cells correlate with
improved patient survival. Patients in high IL-17-producing cell density group exhibited significantly better survival than the low IL-17-producing cell
density group (log-rank test: P=0.031).
doi:10.1371/journal.pone.0018219.g002
Table 2. Univariate and multivariate analyses of variables associated with overall Survival.
Variables Univariate analysis Multivariate analysis
HR 95% CI P value HR 95% CI P value
IL-17+TIL (high vs. low) 0.633 0.416–0.964 0.033
* 0.662 0.431–1.015 0.058
Age, ($60 vs. ,60) 1.141 0.752–1.731 0.535
Gender (female vs. male) 0.813 0.490–1.351 0.425
Location(lower/middle/upper) 1.093 0.754–1.585 0.638
Length, ($5 vs. ,5) 1.226 0.801–1.876 0.348
Differentiation (G3/G2/G1) 1.510 1.123–2.032 0.006
* 1.384 1.033–1.856 0.030
*
T( T 3 +T4 vs. T1+T2) 2.233 1.330–3.750 0.002 1.605 0.875–2.942 0.126
N (Yes vs. No) 3.235 2.103–4.979 ,0.001
* 2.176 1.001–4.728 0.050
M (M1 vs. M0) 2.328 0.944–5.741 0.067
TNM (III+IV vs. I+II) 3.477 2.282–5.298 ,0.001
* 1.433 0.632–3.251 0.389
* Statistically significant (P,0.05).
doi:10.1371/journal.pone.0018219.t002
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enriched IL-17 producing cells in the tumor microenvironment
may inhibit tumor invasion. Kaplan-Meier analysis revealed that
increased levels of IL-17 producing cells were linked to better
overall survival in ESCC patients (Figure 2, P=0.031), indicating
that IL-17 producing cell levels could potentially serve as a
prognostic marker for ESCC. Our results are consistent with those
of Kryczek et al, who demonstrated that the presence of IL-
17+TILs correlated with favorable outcome in and enhanced
survival of ovarian cancer patients [28]. Thus, in ESCC, our
results suggest that IL-17 producing cells may mediate antitumor
immunity.
We also detected CD8+ CTLs and CD57+ NK cells in tumor
tissues from ESCC patients using serial tissue sections. Our study
found that infiltrating CD8+ CTLs cells and CD57+ NK cells
were present in ESCC tumors, and the abundance of CD8+ To r
CD57+ cells correlated positively with the number of IL-17
producing cells. Martin-Orozco et al reported that Th17 cells can
induce a strong antitumor CD8 response by eliciting the priming
and recruitment of CD8+ T cells in a mouse model of lung
melanoma [30]. Benchetrit et al found that IL-17 could inhibit
tumor growth by inducing tumor-specific cytotoxic T lymphocyte
(CTL) activity in hematopoietic tumors in immunocompetent
mice [27]. In addition, Kryczek et al reported that both natural
killer cell-mediated innate immunity and tumor-specific T-cell
immunity were weakened in IL-17 deficient mice bearing MC38
tumors [29]; they also demonstrated that the abundance of IL-17
producing cells correlated positively with CD8+ T and NK cells in
the same tumor microenvironment [28]. Our results are consistent
with these studies, and indicate that IL-17 producing cells in
ESCC might exert antitumor effects by enhancing cytotoxic T
lymphocytes and NK cell responses.
In conclusion, our data show that IL-17 producing TILs were
detected in ESCC, and the density of IL-17+ TILs was associated
with better overall survival. Furthermore, the number of IL-17
producing cells correlated positively with the numbers of CD8+
CTLs and CD57 + NK cells. Thus, tumor infiltrating IL-17
producing cells may constitute a novel prognosis marker for ESCC
Figure 3. Representative photomicrographs showing immunohistochemical staining of IL-17, CD8 and CD57 in the same ESCC
tissues. (A) Low density of IL-17 producing cells. (B) Low density of CD8+ CTLs cells. (C) Low density of CD57+ NK cells. (D) High density of IL-17
producing cells. (E) High density of CD8+ CTLs cells. (F) High density of CD57+ NK cells (original magnification 6400).
doi:10.1371/journal.pone.0018219.g003
Figure 4. IL-17 producing cells correlated positively with the densities of CD8+ CTLs and CD57+ NK cells. The correlation between the
densities of IL-17 producing cells and CD8+T lymphocytes (A), CD57+NK cells (B). The samples were divided into two groups based on the median
value of IL-17 producing cells.
doi:10.1371/journal.pone.0018219.g004
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Materials and Methods
Patients and tissue samples
Paraffin-embedded samples were obtained from 181 ESCC
patients who underwent surgery at the Sun Yat-sen University
Cancer Center between 2002 and 2003. There were 141 male and
40 female patients with a median age of 56 years (range, 33–79
years). Patients with autoimmune diseases and other esophageal
cancers (e.g., adenocarcinoma) were excluded. None of the
patients had received anticancer treatment prior to surgery. The
follow-up data from the ESCC patients in this study are available
and complete. There were 117 cases of stage I–II and 64 cases of
stage III–IV cancer according to the American Joint Committee
on Cancer (AJCC, 2002) TNM staging system. Each lesion was
graded histologically according to the WHO classification criteria.
Overall survival (OS) was defined as the interval between the date
of surgery and date of death or the last known follow-up. The
study was approved by the Ethics Committee of Sun Yat-sen
University Cancer Center, and informed consent was obtained
from each patient.
Immunohistochemistry and immunofiuorescence
Formalin-fixed, paraffin-embedded samples were cut at a
thickness of 2 mm. Each tissue section was deparaffinized and
rehydrated through graded ethanol. For antigen retrieval, the
slides were boiled in EDTA (1 mM, pH 8.0) for 15 min in a
microwave oven. Endogenous peroxidase activity was blocked
with 0.3% hydrogen peroxide solution for 10 min at room
temperature. After rinsing with PBS, the slides were incubated
overnight at 4uC with primary monoclonal antibodies, including
goat anti-human IL-17 (R&D systems; dilution 1/300), mouse
anti-CD8 (Zhong shan Golden Bridge Biotech., Beijing, China;
dilution 1/100), rabbit anti-CD57 (Zhongshan Golden Bridge
Biotech., Beijing, China; dilution 1/100). After three washes in
PBS, sections were incubated with biotinylated secondary
antibody (Zhongshan Golden Bridge Biotech., Beijing, China)
for 30 min at room temperature. Finally, the visualization signal
was developed with 3, 39-diaminobenzidine tetrahydrochloride
(DAB), and all slides were counterstained with hematoxylin. Some
paraffin-embedded specimens were simultaneously incubated with
goat anti-IL-17 (R&D systems; dilution 1/100) and rabbit anti-
CD4 (Zhongshan Golden Bridge Biotech., Beijing, China; dilution
1/50), or with goat anti-IL-17 (R&D systems; dilution 1/100) and
mouse anti-FOXP3 (abcam; dilution 1/100), followed by Phyco-
erythrin-conjugated Affinipure donkey anti-goat IgG(H+L) (Pro-
teintech Group; dilution 1/50) and Fluorescein (FITC)-conjugated
Affinipure donkey anti-rabbit IgG(H+L) (Proteintech Group;
dilution 1/50), or by Alexa Fluor 488 donkey anti-goat IgG
(H+L) (Molecular Probes; concentration 10 mg/ml) and Alexa
Fluor 594 donkey anti-mouse IgG (H+L) (Molecular Probes;
concentration 10 mg/ml).
Data were obtained by manually counting positively stained
cells in ten separate fields under 4006high power magnification.
The density of stained cells was determined by computing the
mean number of positively stained cells per high power
microscopic field (HPF).
Statistical analysis
Quantitative values were expressed as means 6 SD or median
(range). Patients were divided into two groups based on the median
of various immunohistochemical variables in our data (high level
group vs. low level group). The Chi-square test or Fisher exact test
was used to assess the relationships between the levels of IL-17
producing cells and clinicopathological features. The overall
survival curves were calculated using the Kaplan-Meier method
Figure 5. Kaplan–Meier survival curves of ESCC patients (n=181) after surgical resection. Increased tumor-infiltrating CD8+ CTLs and
CD57+ NK cells predict improved patient survival. (A) The survival rate for patients in the high CD8+ CTLs density group was significantly better than
that for patients in the low density group (log rank test, P,0.001). (B) Kaplan–Meier survival curves for high CD57+ NK cell density group versus low
CD57+ NK cell density group showed a highly significant separation (log-rank test: P=0.002).
doi:10.1371/journal.pone.0018219.g005
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examined by univariate and multivariate analyses using the Cox
proportional hazards model. The correlation between the density of
IL-17 producing cells and CD8+ CTLs or CD57+ NK cells were
determined by Pearson correlation coefficient and linear regression
analyses. A two-tailed P-value,0.05 was considered statistically
significant. All statistical analyses were performed with SPSS
software (version 16.0; SPSS Inc., Chicago, IL, USA).
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